ID   HUES 48
AC   CVCL_B181
SY   HUES48; HuES48
DR   EFO; EFO_0007083
DR   BioSample; SAMN00849560
DR   BioSample; SAMN03732527
DR   BioSample; SAMN04096428
DR   ENCODE; ENCBS099BXQ
DR   ENCODE; ENCBS203SNR
DR   ENCODE; ENCBS395IFY
DR   ENCODE; ENCBS585ALE
DR   GEO; GSM621598
DR   GEO; GSM637767
DR   GEO; GSM669936
DR   GEO; GSM669942
DR   GEO; GSM669954
DR   GEO; GSM670013
DR   GEO; GSM670039
DR   GEO; GSM772755
DR   GEO; GSM772766
DR   GEO; GSM772780
DR   GEO; GSM772793
DR   GEO; GSM772794
DR   GEO; GSM772796
DR   GEO; GSM772797
DR   GEO; GSM772798
DR   GEO; GSM772799
DR   GEO; GSM909322
DR   GEO; GSM997250
DR   NIHhESC; NIHhESC-10-0053
DR   SKIP; SKIP001529
DR   Wikidata; Q54896785
RX   PubMed=19200798;
RX   PubMed=21295703;
RX   PubMed=28445466;
CC   From: Harvard University; Boston; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-10-0053.
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K27me3.
CC   Omics: Genomics; ChIP-seq; H3K36me3.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Genomics; ChIP-seq; H3K9ac.
CC   Omics: Genomics; ChIP-seq; H3K9me3.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=19200798
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 12,13
ST   D16S539: 11,12
ST   D18S51: 12,13
ST   D19S433: 14,15
ST   D21S11: 30.2,31.2
ST   D2S1338: 20,21
ST   D3S1358: 15,16
ST   D5S818: 12,13
ST   D7S820: 9
ST   D8S1179: 10,13
ST   FGA: 21,24
ST   TH01: 9.3
ST   TPOX: 8
ST   vWA: 14,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 24
//
RX   PubMed=19200798; DOI=10.1016/j.stem.2008.12.001; PMCID=PMC3335201;
RA   Chen A.E., Egli D.M., Niakan K.K., Deng J., Akutsu H., Yamaki M.,
RA   Cowan C.A., Fitz-Gerald C., Zhang K., Melton D.A., Eggan K.C.;
RT   "Optimal timing of inner cell mass isolation increases the efficiency
RT   of human embryonic stem cell derivation and allows generation of
RT   sibling cell lines.";
RL   Cell Stem Cell 4:103-106(2009).
//
RX   PubMed=21295703; DOI=10.1016/j.cell.2010.12.032; PMCID=PMC3063454;
RA   Bock C., Kiskinis E., Verstappen G., Gu H.-C., Boulting G.L., Smith Z.D.,
RA   Ziller M.J., Croft G.F., Amoroso M.W., Oakley D.H., Gnirke A.,
RA   Eggan K.C., Meissner A.;
RT   "Reference maps of human ES and iPS cell variation enable
RT   high-throughput characterization of pluripotent cell lines.";
RL   Cell 144:439-452(2011).
//
RX   PubMed=28445466; DOI=10.1038/nature22312; PMCID=PMC5427175;
RA   Merkle F.T., Ghosh S., Kamitaki N., Mitchell J., Avior Y., Mello C.,
RA   Kashin S., Mekhoubad S., Ilic D., Charlton M., Saphier G.,
RA   Handsaker R.E., Genovese G., Bar S., Benvenisty N., McCarroll S.A.,
RA   Eggan K.C.;
RT   "Human pluripotent stem cells recurrently acquire and expand dominant
RT   negative p53 mutations.";
RL   Nature 545:229-233(2017).
//